GSK-200630

Study Sponsor: GSK

Study Title

A randomised, double blind (sponsor unblinded), placebo-controlled, single ascending dose study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of a IV dose of GSK2831781 in healthy volunteers and patients with plaque psoriasis

Medicine or Vaccine (generic name)

GSK2831781

Sponsor Identification Number

200630

Trial Registry Identification Number(#'s)

NCT02195349 2014-000312-33

Medical Condition

Psoriasis

Phase

Phase 1

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=200630

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT02195349

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=/2014-000312-33

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

January 2021